Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Metabolix CEO to Speak at 4th Annual Next Generation Bio-Based Chemicals Summit

Metabolix Inc.
Posted on: 24 Jan 13

Metabolix, Inc. (NASDAQ: MBLX), a leading industrial biotechnology company focused on developing clean, sustainable solutions for plastics, chemicals and energy, today announced that President and CEO, Richard P. Eno, will present at the 4th Annual Next Generation Bio-Based Chemicals Summit’s “Molecules to Market” symposium. Mr. Eno’s presentation, “Suppliers’ Perspectives on Bringing a Novel BioPlastic Resin to Market,” will discuss the importance of foundational technology in accessing different biobased markets, and how to build a successful commercial model – drawing on Metabolix's own experience in biotechnology scale-up.

What:

  “Suppliers’ Perspectives on Bringing a Novel BioPlastic Resin to Market”
 

Who:

Richard Eno, president and CEO, Metabolix, Inc.
 

When:

Monday, January 28, 2013 from 2:45-3:15 p.m. PT

 

Where:

4th Annual Next Generation Bio-Based Chemicals Summit

Hilton Del Mar
3939 Ocean Bluff Avenue, San Diego, CA 92130

About the Speaker

Richard P. Eno has served as president, CEO and director since March 2008. Mr. Eno has more than 25 years of professional experience in the chemicals and energy business. Prior to joining Metabolix, Mr. Eno served as vice president, leader global oil & gas sector at CRA International, a leading provider of management consulting services and economic and financial expertise to global companies. Earlier in his career, he held various roles at Arthur D. Little and Chevron Corporation. Mr. Eno holds a bachelor of science degree in chemical engineering from Cornell University, a master of business administration degree from the University of Houston and is a chartered financial analyst.

About Metabolix

Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix’s biobased chemicals platform utilizes its novel “FAST” recovery process to enable the production of cost-effective, “drop-in” replacements for petroleum-based industrial chemicals. The Company is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit www.metabolix.com. (MBLX-G)

Business Wire
http://www.businesswire.com/

Last updated on: 24/01/2013

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.